Cellular Therapy for Neurological Injury

Häftad, Engelska, 2021

785 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Cellular Therapy for Neurological Injury discusses the current status of cellular therapy for neurological disorders. The primary areas of focus include traumatic brain injury, stroke (ischemic and hemorrhagic), and spinal cord injury. The book explores cell therapy approaches to these and other conditions, while discussing current advances and a literature review in the context of a field that is moving rapidly. The book presents a translational focus, addressing barriers and opportunities to moving forward. The mechanisms of injury are explored, as well as how these mechanisms influence the type of cell therapy used, the route of delivery, and dosing regimen. Written by leaders in the field, this is an invaluable resource for clinicians and researchers alike.

Produktinformation

Utgivningsdatum:2021-09-30
Mått:156 x 234 x 17 mm
Vikt:421 g
Format:Häftad
Språk:Engelska
Serie:Gene and Cell Therapy
Antal sidor:304
Förlag:Taylor & Francis Ltd
ISBN:9781032179544

Utforska kategorier

Neurologi och klinisk neurofysiologi inom Medicin
Regenerativ medicin inom Medicin
Neurokirurgi inom Medicin

Mer om författaren

Edited byCharles S. Cox, Jr., MD, University of Texas, Houston, USA

Innehållsförteckning

Acute Neurological Injury: Pathophysiology as Related to Therapeutic Targets. Oligodendrocyte Precursor Cells in Spinal Cord Injury Repair. Cell-Based Therapy for Stroke. Experimental Models of Traumatic Brain Injury: Clinical Relevance and Shortcomings. Behavioral Testing after Experimental Traumatic Brain Injury. Translation Biomarkers for Traumatic Brain Injury. Neuro-Immune Signaling Circuit in Traumatic Brain Injury. Soluble Factors and Mechanisms of Action of Mesenchymal Stem Cells in Traumatic Brain Injury and Organ Injury Induced by Trauma. Use of a Natural Modulator of Inflammation (TSG-6) for the Therapy of Traumatic Brain Injury. Tissue Engineering and Cell-Based Therapeutics for Repair of Myelomeningocele.